Dilona 25mg Injection
₹5.16
PRODUCT INTRODUCTION
Dilona 25mg Injection is a pain-relieving medicine. It is used to treat pain, swelling, stiffness, and joint pain in conditions like rheumatoid arthritis, osteoarthritis, and acute musculoskeletal injuries. It is given in cases where oral administration is not possible.
Dilona 25mg Injection is administered as an injection by a healthcare professional. Kindly do not self administer. Inform your doctor if you have any history of heart disease or stroke. Please consult your doctor in case any injection site reactions like pain, swelling, or redness are observed.
The most common side effects of this medicine include nausea, limb discomfort, and injection site reactions. Your doctor may regularly monitor your kidney function, liver function, and levels of blood components if you are taking this medicine for long-term treatment. Long term use may lead to serious complications such as stomach bleeding and kidney problems.
USES OF DILONA INJECTION
- Pain relief
BENEFITS OF DILONA INJECTION
In Pain relief
Dilona 25mg Injection belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). It is used for short-term relief of pain, inflammation, and swelling in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis.
Take it as it is prescribed to get the most benefit. Do not take more or longer than needed as that can be dangerous. In general, you should take the lowest dose that works, for the shortest possible time. This will help you to go about your daily activities more easily and have a better, more active, quality of life.
SIDE EFFECTS OF DILONA INJECTION
Common side effects of Dilona
- Limb pain
- Injection site reactions (pain, swelling, redness)
- Edema (swelling)
- Nausea
- Headache
- Dizziness
- Vomiting
- Itching
- Flatulence
- Indigestion
- Pain in extremities
Reviews
There are no reviews yet.